Sara Vliet

Dr. Sara Vliet

ORISE, U.S. Environmental Protection Agency, Great Lakes Toxicology and Ecology Division, Duluth, MN, USA
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2018 in Environmental Science & Technology
Verified
Journal Article
Closed access
SDSubham Dasgupta
Subham Dasgupta
VCVanessa Cheng
Vanessa Cheng
Sara VlietSara Vliet
Sara Vliet
CMConstance A. Mitchell
Constance A. Mitchell
David VolzDavid Volz
David Volz

1 August 2017 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
Sara VlietSara Vliet
Sara Vliet
THTrina C. Ho
Trina C. Ho
David VolzDavid Volz
David Volz

14 December 2017 in PeerJ
Verified
Journal Article
Open access
PDF file
SDSubham Dasgupta
Subham Dasgupta
Sara VlietSara Vliet
Sara Vliet
AKAllison Kupsco
Allison Kupsco
JLJessica K. Leet
Jessica K. Leet
DADiego Altomare
Diego Altomare
David VolzDavid Volz
David Volz
Tris(1,3-dichloro-2-propyl) phosphate (TDCIPP) is a high-production volume organophosphate flame retardant widely used within the United States. Within zebrafish, initiation of TDCIPP exposure at 0.75 h post-fertilization (hpf) results in genome-wide alterations in methylation during cleavage (2 hpf) as well as epiboly delay or arrest (at higher concentrations) during late-blastula and early-gastrula (4–6 hpf). To determine whether these TDCIPP-induced effects were associated with impacts on the transcriptome, embryos were exposed to vehicle (0.1% DMSO) or 2 µM TDCIPP from 0.75 hpf to 6 hpf, and total RNA was extracted from triplicate embryo pools per treatment and hybridized onto duplicate Affymetrix Zebrafish Gene 1.0 ST Arrays per RNA sample. Based on transcriptome-wide profiling, TDCIPP resulted in a significant impact on biological processes involved in dorsoventral patterning and bone morphogenetic protein (BMP) signaling. Consistent with these responses, TDCIPP exposure also resulted in strongly dorsalized embryos by 24 hpf—a phenotype that mimicked the effects of dorsomorphin, a potent and selective BMP inhibitor. Moreover, the majority of dorsalized embryos were preceded by epiboly arrest at 6 hpf. Our microarray data also revealed that the expression of sizzled (szl)—a gene encoding a secreted Frizzled-related protein that limits BMP signaling—was significantly decreased by nearly 4-fold at 6 hpf. Therefore, we used a splice-blocking morpholino to test the hypothesis that knockdown ofszlphenocopies TDCIPP-induced delays in epiboly progression. Interestingly, contrary to our hypothesis, injection ofszlMOs did not affect epiboly progression but, similar tochordin(chd) morphants, resulted in mildly ventralized embryos by 24 hpf. Overall, our findings suggest that TDCIPP-induced epiboly delay may not be driven by decreasedszlexpression, and that TDCIPP-induced dorsalization may—similar to dorsomorphin—be due to interference with BMP signaling during early zebrafish development.

15 February 2023 in Environmental Toxicology and Chemistry
Verified
Journal Article
Open access
CMConstance Mitchell
Constance Mitchell
NBNatalie Burden
Natalie Burden
MBMark Bonnell
Mark Bonnell
MHMarkus Hecker
Markus Hecker
THThomas H. Hutchinson
Thomas H. Hutchinson
MEMichelle R. Embry
Michelle R. Embry
Multiple in vivo test guidelines focusing on the estrogen, androgen, thyroid, and steroidogenesis pathways have been developed and validated for mammals, amphibians, or fish. However, these tests are resource-intensive and often use a large number of laboratory animals. Developing alternatives for in vivo tests is consistent with the replacement, reduction, and refinement principles for animal welfare considerations, which are supported by increasing mandates to move toward an “animal-free” testing paradigm worldwide. New approach methodologies (NAMs) hold great promise to identify molecular, cellular, and tissue changes that can be used to predict effects reliably and more efficiently at the individual level (and potentially on populations) while reducing the number of animals used in (eco)toxicological testing for endocrine disruption. In a collaborative effort, experts from government, academia, and industry met in 2020 to discuss the current challenges of testing for endocrine activity assessment for fish and amphibians. Continuing this cross-sector initiative, our review focuses on the current state of the science regarding the use of NAMs to identify chemical-induced endocrine effects. The present study highlights the challenges of using NAMs for safety assessment and what work is needed to reduce their uncertainties and increase their acceptance in regulatory processes. We have reviewed the current NAMs available for endocrine activity assessment including in silico, in vitro, and eleutheroembryo models. New approach methodologies can be integrated as part of a weight-of-evidence approach for hazard or risk assessment using the adverse outcome pathway framework. The development and utilization of NAMs not only allows for replacement, reduction, and refinement of animal testing but can also provide robust and fit-for-purpose methods to identify chemicals acting via endocrine mechanisms. Environ Toxicol Chem 2023;42:757–777. © 2023 The Authors. Environmental Toxicology and Chemistry published by Wiley Periodicals LLC on behalf of SETAC.

1 February 2019 in Science of The Total Environment
Verified
Journal Article
Closed access
LBLuísa Becker Bertotto
Luísa Becker Bertotto
SDSubham Dasgupta
Subham Dasgupta
Sara VlietSara Vliet
Sara Vliet
SDStacia Dudley
Stacia Dudley
JGJay Gan
Jay Gan
DSDaniel Schlenk
Daniel Schlenk

1 October 2019 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
Sara VlietSara Vliet
Sara Vliet
SDSubham Dasgupta
Subham Dasgupta
NSNicole R.L. Sparks
Nicole R.L. Sparks
JKJay S. Kirkwood
Jay S. Kirkwood
AVAlyssa Vollaro
Alyssa Vollaro
David VolzDavid Volz
David Volz